CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net earnings	$ 347,230	$ 287,126
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	93,319	80,844
Loss on sale/disposal of long-lived assets	356	51
Deferred income taxes	5,538	(12,969)
Share-based compensation	16,610	15,164
Non-cash restructuring charges	468	3,049
Change in operating assets and liabilities, net of businesses acquired:
Receivables, net	(128,774)	(120,795)
Inventories, net	(86,139)	(71,683)
Accounts payable and accrued expenses	28,480	(15,206)
Deferred revenue	40,119	85,579
Net pension and postretirement liabilities	(14,433)	(13,218)
Other current and long-term assets and liabilities	(12,116)	5,034
Net cash provided by operating activities	290,658	242,976
Cash flows from investing activities:
Proceeds from sale/disposal of long-lived assets	424	1,206
Additions to property, plant, and equipment	(52,054)	(37,703)
Proceeds from sale of equity securities	7,919	0
Acquisition of business, net of cash acquired	0	(33,756)
Additional consideration paid on prior year acquisitions	(9,619)	0
Net cash used for investing activities	(53,330)	(70,253)
Cash flows from financing activities:
Borrowings under revolving credit facility	271,354	16,615
Payments of revolving credit facilities	(260,854)	(16,615)
Principal payments on debt	(90,000)	0
Repurchases of common stock	(325,112)	(137,580)
Proceeds from share-based compensation	12,538	11,345
Dividends paid	(16,967)	(15,707)
Other	(940)	(876)
Net cash used for financing activities	(409,981)	(142,818)
Effect of exchange-rate changes on cash	13,038	7,078
Net increase (decrease) in cash and cash equivalents	(159,615)	36,983
Cash and cash equivalents at beginning of period	385,042	406,867
Cash and cash equivalents at end of period	$ 225,427	$ 443,850